ELOVL6 and lysosomal storage disease: However, it is clear that our model predicts that the induction of phospholipidosis via the mechanism 3 targets ELOVL6 or SCD is unlikely, as neither is predicted to interact with any of the 100 positive phospholipidosis-inducing compounds.